Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Jenkins

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
The Journal of Family Practice|August 1, 1989
Compliance with five health promotion recommendations in a university-based family practiceS M Ornstein, D R Garr, R G Jenkins, et al.
Nature Reviews. Drug Discovery|September 18, 2021
Emerging therapeutic opportunities for integrin inhibitorsR J Slack, S J F Macdonald, J A Roper, et al.
Archives of Family Medicine|September 1, 1994
Improving a preventive services reminder system using feedback from focus groupsS M Ornstein, C Musham, A O Reid, et al.
Quality & Safety in Health Care|April 24, 2010
Medication prescribing and monitoring errors in primary care: a report from the Practice Partner Research NetworkA M Wessell, C Litvin, R G Jenkins, et al.
Journal of Biochemical and Biophysical Methods|April 1, 1980
Rapid analysis of naphthalene and its metabolites in biological systems: determination by high-performance liquid chromatography/fluorescence detection and by plasma desorption/chemical ionization mass spectrometryM M Krahn, D W Brown, T K Collier, et al.
Thorax|April 29, 2011
The rising incidence of idiopathic pulmonary fibrosis in the U.KV Navaratnam, K M Fleming, J West, et al.
The American Journal of the Medical Sciences|June 30, 2000
Antibiotics and return visits for respiratory illness: a comparison of pooled versus hierarchical statistical methodsQ Pan, S Ornstein, A J Gross, et al.
Gene Therapy|March 1, 2000
An integrin-targeted non-viral vector for pulmonary gene therapyR G Jenkins, S E Herrick, Q H Meng, et al.
Biochemical and Biophysical Research Communications|March 17, 1997
Oreganic acid, a potent inhibitor of ras farnesyl-protein transferaseK C Silverman, H Jayasuriya, C Cascales, et al.
European Journal of Preventive Cardiology|February 13, 2025
The association between fibrotic diseases and treatment resistant hypertension in EnglandG M Massen, P W Stone, R G Jenkins, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
The Journal of Family Practice|August 1, 1989
Compliance with five health promotion recommendations in a university-based family practiceS M Ornstein, D R Garr, R G Jenkins, et al.
Nature Reviews. Drug Discovery|September 18, 2021
Emerging therapeutic opportunities for integrin inhibitorsR J Slack, S J F Macdonald, J A Roper, et al.
Archives of Family Medicine|September 1, 1994
Improving a preventive services reminder system using feedback from focus groupsS M Ornstein, C Musham, A O Reid, et al.
Quality & Safety in Health Care|April 24, 2010
Medication prescribing and monitoring errors in primary care: a report from the Practice Partner Research NetworkA M Wessell, C Litvin, R G Jenkins, et al.
Journal of Biochemical and Biophysical Methods|April 1, 1980
Rapid analysis of naphthalene and its metabolites in biological systems: determination by high-performance liquid chromatography/fluorescence detection and by plasma desorption/chemical ionization mass spectrometryM M Krahn, D W Brown, T K Collier, et al.
Thorax|April 29, 2011
The rising incidence of idiopathic pulmonary fibrosis in the U.KV Navaratnam, K M Fleming, J West, et al.
The American Journal of the Medical Sciences|June 30, 2000
Antibiotics and return visits for respiratory illness: a comparison of pooled versus hierarchical statistical methodsQ Pan, S Ornstein, A J Gross, et al.
Gene Therapy|March 1, 2000
An integrin-targeted non-viral vector for pulmonary gene therapyR G Jenkins, S E Herrick, Q H Meng, et al.
Biochemical and Biophysical Research Communications|March 17, 1997
Oreganic acid, a potent inhibitor of ras farnesyl-protein transferaseK C Silverman, H Jayasuriya, C Cascales, et al.
European Journal of Preventive Cardiology|February 13, 2025
The association between fibrotic diseases and treatment resistant hypertension in EnglandG M Massen, P W Stone, R G Jenkins, et al.
Pageof 4